161 related articles for article (PubMed ID: 38245662)
1. Predicting 5-year recurrence risk in colorectal cancer: development and validation of a histology-based deep learning approach.
Xiao H; Weng Z; Sun K; Shen J; Lin J; Chen S; Li B; Shi Y; Kuang M; Song X; Weng W; Peng S
Br J Cancer; 2024 Apr; 130(6):951-960. PubMed ID: 38245662
[TBL] [Abstract][Full Text] [Related]
2. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
[TBL] [Abstract][Full Text] [Related]
3. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
Veldhuizen GP; Röcken C; Behrens HM; Cifci D; Muti HS; Yoshikawa T; Arai T; Oshima T; Tan P; Ebert MP; Pearson AT; Calderaro J; Grabsch HI; Kather JN
Gastric Cancer; 2023 Sep; 26(5):708-720. PubMed ID: 37269416
[TBL] [Abstract][Full Text] [Related]
4. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
[TBL] [Abstract][Full Text] [Related]
5. CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study.
Cao W; Hu H; Guo J; Qin Q; Lian Y; Li J; Wu Q; Chen J; Wang X; Deng Y
J Transl Med; 2023 Mar; 21(1):214. PubMed ID: 36949511
[TBL] [Abstract][Full Text] [Related]
6. Deep learning with whole slide images can improve the prognostic risk stratification with stage III colorectal cancer.
Sun C; Li B; Wei G; Qiu W; Li D; Li X; Liu X; Wei W; Wang S; Liu Z; Tian J; Liang L
Comput Methods Programs Biomed; 2022 Jun; 221():106914. PubMed ID: 35640390
[TBL] [Abstract][Full Text] [Related]
7. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
[TBL] [Abstract][Full Text] [Related]
8. End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study.
Jiang X; Hoffmeister M; Brenner H; Muti HS; Yuan T; Foersch S; West NP; Brobeil A; Jonnagaddala J; Hawkins N; Ward RL; Brinker TJ; Saldanha OL; Ke J; Müller W; Grabsch HI; Quirke P; Truhn D; Kather JN
Lancet Digit Health; 2024 Jan; 6(1):e33-e43. PubMed ID: 38123254
[TBL] [Abstract][Full Text] [Related]
9. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Nishimura Y; Katoh H; Yamashita K; Watanabe M; Yamaguchi K
J Gastrointest Surg; 2017 May; 21(5):867-878. PubMed ID: 28251467
[TBL] [Abstract][Full Text] [Related]
10. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
Kleppe A; Skrede OJ; De Raedt S; Hveem TS; Askautrud HA; Jacobsen JE; Church DN; Nesbakken A; Shepherd NA; Novelli M; Kerr R; Liestøl K; Kerr DJ; Danielsen HE
Lancet Oncol; 2022 Sep; 23(9):1221-1232. PubMed ID: 35964620
[TBL] [Abstract][Full Text] [Related]
11. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
Kather JN; Krisam J; Charoentong P; Luedde T; Herpel E; Weis CA; Gaiser T; Marx A; Valous NA; Ferber D; Jansen L; Reyes-Aldasoro CC; Zörnig I; Jäger D; Brenner H; Chang-Claude J; Hoffmeister M; Halama N
PLoS Med; 2019 Jan; 16(1):e1002730. PubMed ID: 30677016
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer.
Li X; Jonnagaddala J; Yang S; Zhang H; Xu XS
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1955-1963. PubMed ID: 35332389
[TBL] [Abstract][Full Text] [Related]
13. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided detection and prognosis of colorectal cancer on whole slide images using dual resolution deep learning.
Xu Y; Jiang L; Chen W; Huang S; Liu Z; Zhang J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):91-101. PubMed ID: 36331654
[TBL] [Abstract][Full Text] [Related]
15. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
16. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
[TBL] [Abstract][Full Text] [Related]
18. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
19. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
20. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
Front Immunol; 2021; 12():724429. PubMed ID: 34512652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]